Published : Aug-2021
No. of Pages : 56
1 Head and Neck Squamous Cell Carcinoma: Executive Summary
1.1 Catalyst
1.2 Related Reports
1.3 Upcoming Reports
2 Epidemiology
2.1 Disease Background
2.2 Risk Factors and Comorbidities
2.3 Global and Historical Trends
2.4 8MM Forecast Methodology
2.4.1 Sources
2.4.2 Forecast Assumptions and Methods
2.4.3 Forecast Assumptions and Methods: Diagnosed Incident Cases of HNC
2.4.4 Forecast Assumptions and Methods: Diagnosed Incident Cases of HNC by Histology Distribution
2.4.5 Forecast Assumptions and Methods: Diagnosed Incident Cases of HNC by Clinical Stage at Diagnosis for Squamous Cell Carcinoma
2.4.6 Forecast Assumptions and Methods: Diagnosed Incident Cases of Oropharynx Cancer by Risk Factor (HPV+ and HPV-)
2.4.7 Forecast Assumptions and Methods: Diagnosed Incident Cases of Nasopharynx Cancer by Risk Factor (EBV+)
2.4.8 Forecast Assumptions and Methods: Tobacco Smoking History
2.4.9 Forecast Assumptions and Methods: Five-Year Diagnosed Prevalent Cases of HNC
2.5 Epidemiological Forecast for HNC (2020-2030)
2.5.1 Diagnosed Incident Cases of Lip, Oral Cavity, Pharynx, and Larynx Cancer (ICD-10 = C00-C06, C09, C12-C14, C32, and C10 [HPV-])
2.5.2 Diagnosed Incident Cases of Lip, Oral Cavity, Pharynx, and Larynx Cancer (ICD-10 = C00-C06, C09, C12-C14, C32, and C10 [HPV-]) by Risk Factor, Histology Distribution, and Stage at Diagnosis
2.5.3 Five-Year Diagnosed Prevalent Cases of Lip, Oral Cavity, Pharynx, and Larynx Cancer (ICD-10 = C00-C06, C09, C12-C14, C32, and C10 [HPV-])
2.5.4 Diagnosed Incident Cases of Oropharynx Cancer (ICD-10 = C10)
2.5.5 Diagnosed Incident Cases of Oropharynx Cancer by Risk Factors, Histology Distribution, and Stage at Diagnosis
2.5.6 Diagnosed Incident Cases of Nasopharynx Cancer (ICD-10 = C11)
2.5.7 Age-Specific Diagnosed Incident Cases of Nasopharynx Cancer
2.5.8 Sex-Specific Diagnosed Incident Cases of Nasopharynx Cancer
2.5.9 Diagnosed Incident Cases of Nasopharynx Cancer by Risk Factors, Histology Distribution, and Stage at Diagnosis
2.5.10 Five-Year Diagnosed Prevalent Cases of Nasopharynx Cancer
2.5.11 Diagnosed Incident Cases of Salivary Gland and Nose, Sinuses, and Other Related Structures Cancer (ICD-10 = C07-C08 and C30-C31)
2.5.12 Age-Specific Diagnosed Incident Cases of Salivary Gland and Nose, Sinuses, and Other Related Structures Cancer
2.5.13 Sex-Specific Diagnosed Incident Cases of Salivary Gland and Nose, Sinuses, and Other Related Structures Cancer
2.5.14 Diagnosed Incident Cases of Salivary Gland and Nose, Sinuses, and Other Related Structures Cancer by Risk Factors, Histology Distribution, and Stage at Diagnosis
2.5.15 Five-Year Diagnosed Prevalent Cases of Salivary Gland and Nose, Sinuses, and Other Related Structures Cancer
2.6 Discussion
2.6.1 Epidemiological Forecast Insight
2.6.2 COVID-19 Impact
2.6.3 Limitations of the Analysis
2.6.4 Strengths of the Analysis
3 Appendix
3.1 Bibliography
3.2 About the Authors
3.2.1 Epidemiologist
3.2.2 Reviewers
3.2.3 Global Director of Therapy Analysis and Epidemiology
3.2.4 Global Head and EVP of Healthcare Operations and Strategy
Contact Us
List of Tables
Table 1: Summary of Newly Added Data Types
Table 2: Summary of Updated Data Types
Table 3: Risk Factors and Comorbid Conditions Associated with HNCs
Table 4: 8MM, Diagnosed Incident Cases of Lip, Oral Cavity, Pharynx, and Larynx Cancer by Risk Factor, Histology Distribution, and Stage at Diagnosis, Both Sexes, Ages ?18 Years, N, 2020
Table 5: 8MM, Diagnosed Incident Cases of Oropharynx Cancer by Risk Factor, Histology Distribution, and Stage at Diagnosis, Both Sexes, Ages ?18 Years, N, 2020
Table 6: 8MM, Diagnosed Incident Cases of Nasopharynx Cancer by Risk Factors, Histology Distribution, and Stage at Diagnosis, Both Sexes, Ages ?18 Years, N, 2020
Table 7: 8MM, Diagnosed Incident Cases of Salivary Gland and Nose, Sinuses, and Other Related Structures Cancer by Risk Factor, Histology Distribution, and Stage at Diagnosis, Both Sexes, Ages ?18 Years, N, 2020
List of Figures
Figure 1: 8MM, Diagnosed Incident Cases of HNC, Both Sexes, N, Ages ?18 Years, 2020 and 2030
Figure 2: 8MM, Five-Year Diagnosed Prevalent Cases of HNC, Both Sexes, N, Ages ?18 Years, 2020 and 2030
Figure 3: 8MM, Diagnosed Incidence of HNC, Men and Women (Cases per 100,000 Population), Ages ?18 Years, 2020
Figure 4: 8MM, Sources Used, Diagnosed Incident Cases of Lip, Oral Cavity, Pharynx, and Larynx Cancer (ICD-10 = C00-C06, C09, C12-C14, C32, and C10 [HPV-])
Figure 5: 8MM, Sources Used, Diagnosed Incident Cases of Oropharynx Cancer (ICD-10 = C10); Nasopharynx Cancer (ICD-10 = C11); Salivary Gland and Nose, Sinuses, and Other Related Structures Cancer (ICD-10 = C07-C08 and C30-C31)
Figure 6: 8MM, Sources Used, Five-Year Prevalent Cases of Lip, Oral Cavity, Pharynx, and Larynx Cancer (ICD-10 = C00-C06, C09, C12-C14, C32, and C10 [HPV-]), Oropharynx Cancer (ICD-10 = C10), Nasopharynx Cancer (ICD-10 = C11), Salivary Gland and Nose, Sinuses, and Other Related Structures Cancer (ICD-10 = C07-C08 and C30-C31)
Figure 7: 8MM, Sources Used to Forecast the Risk Factors and Histology Distribution Among Diagnosed Incident Cases of Lip, Oral Cavity, Pharynx, and Larynx Cancer (ICD-10 = C00-C06, C09, C12-C14, C32, and C10 [HPV-]), Oropharynx Cancer (ICD-10 = C10), Nasopharynx Cancer (ICD-10 = C11), Salivary Gland and Nose, Sinuses, and Other Related Structures Cancer (ICD-10 = C07-C08 and C30-C31)
Figure 8: 8MM, Sources Used to Forecast the Stage at Diagnosis Among Diagnosed Incident Cases of Lip, Oral Cavity, Pharynx, and Larynx Cancer, Oropharynx Cancer, Nasopharynx Cancer, and Salivary Gland and Nose, Sinuses, and Other Related Structures Cancer
Figure 9: 8MM, Diagnosed Incident Cases of Lip, Oral Cavity, Pharynx, and Larynx Cancer, N, Both Sexes, Ages ?18 Years, 2020
Figure 10: 8MM, Five-Year Diagnosed Prevalent Cases of Lip, Oral Cavity, Pharynx, and Larynx Cancer, N, Both Sexes, Ages ?18 Years, 2020
Figure 11: 8MM, Diagnosed Incident Cases of Oropharynx Cancer, N, Both Sexes, Ages ?18 Years, 2020
Figure 12: 8MM, Diagnosed Incident Cases of Nasopharynx Cancer, N, Both Sexes, Ages ?18 Years, 2020
Figure 13: 8MM, Diagnosed Incident Cases of Nasopharynx Cancer by Age, N, Both Sexes, 2020
Figure 14: 8MM, Diagnosed Incident Cases of Nasopharynx Cancer by Sex, N, Ages ?18 Years, 2020
Figure 15: 8MM, Five-Year Diagnosed Prevalent Cases of Nasopharynx Cancer, N, Both Sexes, Ages ?18 Years, 2020
Figure 16: 8MM, Diagnosed Incident Cases of Salivary Gland and Nose, Sinuses, and Other Related Structures Cancer, N, Both Sexes, Ages ?18 Years, 2020
Figure 17: 8MM, Diagnosed Incident Cases of Salivary Gland and Nose, Sinuses, and Other Related Structures Cancer by Age, N, Both Sexes, 2020
Figure 18: 8MM, Diagnosed Incident Cases of Salivary Gland and Nose, Sinuses, and Other Related Structures Cancer by Sex, N, Ages ?18 Years, 2020
Figure 19: 8MM, Five-Year Diagnosed Prevalent Cases of Salivary Gland and Nose, Sinuses, and Other Related Structures Cancer, N, Both Sexes, Ages ?18 Years, 2020
